These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16785518)

  • 1. Tight linkage between translation and MHC class I peptide ligand generation implies specialized antigen processing for defective ribosomal products.
    Qian SB; Reits E; Neefjes J; Deslich JM; Bennink JR; Yewdell JW
    J Immunol; 2006 Jul; 177(1):227-33. PubMed ID: 16785518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA polymerase II inhibitors dissociate antigenic peptide generation from normal viral protein synthesis: a role for nuclear translation in defective ribosomal product synthesis?
    Dolan BP; Knowlton JJ; David A; Bennink JR; Yewdell JW
    J Immunol; 2010 Dec; 185(11):6728-33. PubMed ID: 21048111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct pathways generate peptides from defective ribosomal products for CD8+ T cell immunosurveillance.
    Dolan BP; Li L; Veltri CA; Ireland CM; Bennink JR; Yewdell JW
    J Immunol; 2011 Feb; 186(4):2065-72. PubMed ID: 21228349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective ribosomal products are the major source of antigenic peptides endogenously generated from influenza A virus neuraminidase.
    Dolan BP; Li L; Takeda K; Bennink JR; Yewdell JW
    J Immunol; 2010 Feb; 184(3):1419-24. PubMed ID: 20038640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticosterone impairs MHC class I antigen presentation by dendritic cells via reduction of peptide generation.
    Truckenmiller ME; Princiotta MF; Norbury CC; Bonneau RH
    J Neuroimmunol; 2005 Mar; 160(1-2):48-60. PubMed ID: 15710457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific proteolytic cleavages limit the diversity of the pool of peptides available to MHC class I molecules in living cells.
    Serwold T; Shastri N
    J Immunol; 1999 Apr; 162(8):4712-9. PubMed ID: 10202012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC class I antigen presentation of DRiP-derived peptides from a model antigen is not dependent on the AAA ATPase p97.
    Palmer AL; Dolan BP
    PLoS One; 2013; 8(7):e67796. PubMed ID: 23844095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct delivery of the Bordetella pertussis adenylate cyclase toxin to the MHC class I antigen presentation pathway.
    Guermonprez P; Ladant D; Karimova G; Ullmann A; Leclerc C
    J Immunol; 1999 Feb; 162(4):1910-6. PubMed ID: 9973458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Processing of exogenous antigens for presentation by class I MHC molecules involves post-Golgi peptide exchange influenced by peptide-MHC complex stability and acidic pH.
    Chefalo PJ; Harding CV
    J Immunol; 2001 Aug; 167(3):1274-82. PubMed ID: 11466343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tripeptidyl peptidase II is the major peptidase needed to trim long antigenic precursors, but is not required for most MHC class I antigen presentation.
    York IA; Bhutani N; Zendzian S; Goldberg AL; Rock KL
    J Immunol; 2006 Aug; 177(3):1434-43. PubMed ID: 16849449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous peptides delivered by ricin require processing by signal peptidase for transporter associated with antigen processing-independent MHC class I-restricted presentation.
    Smith DC; Gallimore A; Jones E; Roberts B; Lord JM; Deeks E; Cerundolo V; Roberts LM
    J Immunol; 2002 Jul; 169(1):99-107. PubMed ID: 12077234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains.
    Machy P; Serre K; Baillet M; Leserman L
    J Immunol; 2002 Feb; 168(3):1172-80. PubMed ID: 11801652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tapasin-mediated retention and optimization of peptide ligands during the assembly of class I molecules.
    Barnden MJ; Purcell AW; Gorman JJ; McCluskey J
    J Immunol; 2000 Jul; 165(1):322-30. PubMed ID: 10861068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CpG oligodeoxynucleotides down-regulate macrophage class II MHC antigen processing.
    Chu RS; Askew D; Noss EH; Tobian A; Krieg AM; Harding CV
    J Immunol; 1999 Aug; 163(3):1188-94. PubMed ID: 10415013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying recruitment of cytosolic peptides for HLA class I presentation: impact of TAP transport.
    Fruci D; Lauvau G; Saveanu L; Amicosante M; Butler RH; Polack A; Ginhoux F; Lemonnier F; Firat H; van Endert PM
    J Immunol; 2003 Mar; 170(6):2977-84. PubMed ID: 12626550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitating protein synthesis, degradation, and endogenous antigen processing.
    Princiotta MF; Finzi D; Qian SB; Gibbs J; Schuchmann S; Buttgereit F; Bennink JR; Yewdell JW
    Immunity; 2003 Mar; 18(3):343-54. PubMed ID: 12648452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient and qualitatively distinct MHC class I-restricted presentation of antigen targeted to the endoplasmic reticulum.
    Golovina TN; Wherry EJ; Bullock TN; Eisenlohr LC
    J Immunol; 2002 Mar; 168(6):2667-75. PubMed ID: 11884431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules?
    Yewdell JW; Antón LC; Bennink JR
    J Immunol; 1996 Sep; 157(5):1823-6. PubMed ID: 8757297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 26 S proteasome-mediated production of an authentic major histocompatibility class I-restricted epitope from an intact protein substrate.
    Ben-Shahar S; Komlosh A; Nadav E; Shaked I; Ziv T; Admon A; DeMartino GN; Reiss Y
    J Biol Chem; 1999 Jul; 274(31):21963-72. PubMed ID: 10419519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of the proteasome subunits LMP2, LMP7, and MECL-1, but not PA28 alpha/beta, enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitope.
    Schwarz K; van Den Broek M; Kostka S; Kraft R; Soza A; Schmidtke G; Kloetzel PM; Groettrup M
    J Immunol; 2000 Jul; 165(2):768-78. PubMed ID: 10878350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.